SCHEMBL23641789

SCHEMBL23641789

CC(CC[C@H](C)CO)n1cnc2c(N)nc(I)nc21

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CDK1 P06493 7/20 0.45
▸ CDK2 P24941 3/20 0.45
▸ CCNB1 P14635 2/20 0.45
▸ CCNE1 P24864 2/20 0.45
▸ ADORA1 P30542 5/20 0.42
▸ ADORA2A P29274 3/20 0.42
▸ ADORA2B P29275 2/20 0.42
▸ ADORA3 P0DMS8 6/20 0.41
▸ CDK5 Q00535 2/20 0.38
▸ SLC29A1 Q99808 1/20 0.37
▸ PI4KA P42356 1/20 0.37
▸ PI4K2B Q8TCG2 1/20 0.37
▸ PI4K2A Q9BTU6 1/20 0.37
▸ PI4KB Q9UBF8 1/20 0.37
▸ DNMT1 P26358 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17804436 0.81 ADORA2A (0.66) ADORA1ADORA2AADORA2BPI4KAPI4K2B
SCHEMBL12379218 0.78 CDK1 (0.71) CDK1CDK2CCNB1CCNE1ADORA1
SCHEMBL2152711 0.69 ADORA2A (0.58) ADORA1ADORA2AADORA2BPI4KAPI4K2B
SCHEMBL27748107 0.69 CDK1 (0.54) CDK1CDK2CCNB1CCNE1ADORA1
SCHEMBL5161756 0.68 CDK1 (0.73) CDK1CDK2CCNB1CCNE1ADORA1
SCHEMBL11251758 0.67 ADORA2A (0.75) ADORA1ADORA2AADORA2BPI4KAPI4K2B
SCHEMBL24860314 0.67 ADORA2A (0.75) ADORA1ADORA2AADORA2BPI4KAPI4K2B
SCHEMBL14131868 0.67 CDK1 (0.64) CDK1CDK2CCNB1CCNE1ADORA1
SCHEMBL28083712 0.66 CDK1 (0.76) CDK1CDK2CCNB1CCNE1ADORA1
SCHEMBL233129 0.66 ADORA2A (0.64) CDK1CDK2CCNB1CCNE1ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3848054-A1 NOVEL CYCLIC DINUCLEOTIDE DERIVATIVE AND ANTIBODY-DRUG CONJUGATE THEREOF Daiichi Sankyo Company, Limited (JP) 2021-07-14 — — EP disclosed
Send feedback